2022
DOI: 10.1056/nejmra2104829
|View full text |Cite
|
Sign up to set email alerts
|

Medical Conditions and High-Altitude Travel

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
53
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 85 publications
(60 citation statements)
references
References 66 publications
1
53
0
1
Order By: Relevance
“…With the increasing number of unacclimatized lowlanders traveling to high altitude, the importance of the management of acute high altitude illness is growing. Acute high altitude illness is triggered by hypobaric hypoxia and can be fatal if not treated promptly [ 1 ]. Oxygen supplementation is lifesaving, but this is often impossible in resource-limited regions.…”
Section: To the Editormentioning
confidence: 99%
“…With the increasing number of unacclimatized lowlanders traveling to high altitude, the importance of the management of acute high altitude illness is growing. Acute high altitude illness is triggered by hypobaric hypoxia and can be fatal if not treated promptly [ 1 ]. Oxygen supplementation is lifesaving, but this is often impossible in resource-limited regions.…”
Section: To the Editormentioning
confidence: 99%
“…Resuscitation for moribund alpinists stranded at high altitudes: A stepwise approach including ECMO as a last resort strategy 1…”
Section: E D I T O R I a Lmentioning
confidence: 99%
“…The critical pathophysiology of HAPE involves a hypoxemia‐mediated rise in pulmonary vascular resistance, leading to increased microvascular hydrostatic pressures despite normal left atrial pressure. The resultant hydrostatic stress increases the permeability of the alveolar capillary barrier, and causes leakage of large proteins and erythrocytes in the alveolar space 1 . HACE instead is the result of vasogenic brain edema with raised intracranial pressure, secondary to increased venous pressure, leading to a blood–brain barrier (BBB) leak and the release of biochemical mediators of BBB permeability, namely the vascular endothelial growth factor and reactive oxygen species 2 …”
Section: Introductionmentioning
confidence: 99%
“…In mountains higher than 2,500 m above sea level, high-altitude headache, central sleep apnea, and acute high-altitude illness (AHAI) may develop, especially in people without acclimatization. AHAI, including acute mountain sickness (AMS), high-altitude cerebral edema (HACE), and high-altitude pulmonary edema (HAPE), usually occurs after hours to 4 days because of poor adjustment to an oxygen-decreased environment ( 1 , 2 ). Headache, gastrointestinal symptoms, fatigue/weakness, and dizziness/light-headedness are four major symptoms of AMS.…”
Section: Introductionmentioning
confidence: 99%
“…In severe cases, AMS may progress to HACE with neurologic deficits such as conscious change and/or HAPE featuring dyspnea, cough, frothy sputum, and cyanosis. Slow ascent, premedication (pharmacological prophylaxis), and pre-acclimatization can prevent AHAI ( 2 ).…”
Section: Introductionmentioning
confidence: 99%